STATEMENT OF RELATED APPLICATIONThe present application is a continuation of co-pending U.S. patent application Ser. No. 11/035,657 filed Jan. 14, 2005, in the name of inventor Michael D. Laufer, entitled “System And Method For The Treatment Of Heart Tissue.”
TECHNICAL FIELDThe present invention is related generally to the medical treatment of the heart, including modification of heart tissue for the treatment of myocardial infarction.
BACKGROUNDAs is well known, the heart has four chambers for receiving and pumping blood to various parts of the body. During normal operation of the heart, oxygen-poor blood returning from the body enters the right atrium. The right atrium fills with blood and eventually contracts to expel the blood through the tricuspid valve to the right ventricle. Contraction of the right ventricle ejects the blood in a pulse-like manner into the pulmonary artery and each lung. The oxygenated blood leaves the lungs through the pulmonary veins and fills the left atrium. The left atrium fills with blood and eventually contracts to expel the blood through the mitral valve to the left ventricle. Contraction of the left ventricle forces blood through the aorta to eventually deliver the oxygenated blood to the rest of the body.
Myocardial infarction (i.e., heart attack) can result in congestive heart failure. Congestive heart failure is a condition wherein the heart can not pump enough blood. When patients have a heart attack, part of the circulation to the heart wall muscle is lost usually due to a blood clot which dislodges from a larger artery and obstructs a coronary artery. If the clot is not dissolved within about 3 to 4 hours, the muscle which lost its blood supply necroses and subsequently becomes a scar. The scarred muscle is not contractile, and therefore it does not contribute to the pumping ability of the heart. In addition, the scarred muscle is elastic (i.e., floppy) which further reduces the efficiency of the heart because a portion of the force created by the remaining healthy muscle bulges out the scarred tissue (i.e., ventricular aneurism) instead of pumping the blood out of the heart.
Congestive heart failure is generally treated with lots of rest, a low-salt diet, and medications such as A.C.E. inhibitors, digitalis, vasodilators and diuretics. In some myocardial infarction instances, the scarred muscle is cut out of the heart and the remaining portions of the heart are sutured (i.e., aneurismechtomy). In limited circumstances a heart transplant may be performed. The condition is always progressive and eventually results in patient death.
Collagen-containing tissue is ubiquitous in normal human body tissues. Collagen makes up a substantial portion of scar tissue, including cardiac scar tissue resulting from healing after a heart attack. Collagen demonstrates several unique characteristics not found in other tissues. Intermolecular cross links provide collagen-containing tissue with unique physical properties of high tensile strength and substantial elasticity. A property of collagen is that collagen fibers shorten when heated. This molecular response to temperature elevation is believed to be the result of rupture of the collagen stabilizing cross links and immediate contraction of the collagen fibers to about one-third of their original length. If heated to approximately 70 degrees Centigrade, the cross links will again form at the new dimension. If the collagen is heated above about 85 degrees Centigrade, the fibers will still shorten, but crosslinking will not occur, resulting in denaturation. The denatured collagen is quite expansile and relatively inelastic. In living tissue, denatured collagen is replaced by fibroblasts with organized fibers of collagen than can again be treated if necessary. Another property of collagen is that the caliber of the individual fibers increases greatly, over four fold, without changing the structural integrity of the connective tissue.
U.S. Pat. No. 6,071,303 teaches a device and method for treating infarct scar tissue of a mammalian heart by selectively heating the infarct scar to reduce the size of the scar tissue surface area, increase the cross-section of the scar tissue, stiffen the floppy portion of the scar tissue, reduce the ventricular systolic wall tension, and increase the overall pumping efficiency of the infarcted heart by eliminating the ventricular aneurism or dilated ventricle, if present.FIG. 1 illustrates an embodiment of the device taught in U.S. Pat. No. 6,071,303.
Referring toFIG. 1, there is illustrated aheart10 having an infarcted region orportion12. The infarctedportion12 of the heart can be accessed with conventional open chest surgery. Apositive electrode14 andnegative electrode16 are applied externally to a portion of the infarctedportion12 to induce resistive heating in the infarct scar in the desiredtreatment area18 when energy is applied across the electrodes. Alternatively, the positive and negative electrodes can be inserted into the infarcted scar. The positive and negative electrodes function as a heating element as they are energized to raise the temperature of the scar in the desiredtreatment area18 to a controlled temperature sufficient to reduce the surface area of the scar without ablating the scar tissue or damaging the healthy tissue surrounding the infarctedportion12.
U.S. Pat. No. 6,071,303 also teaches other appliances for applying radiant energy or thermal energy, or to otherwise heat the infarcted tissue and reduce the area of the infarcted tissue. For example, as shown inFIG. 2 a radio-frequency generator20 and heating element applicator22 can be used. When the heating element24 of the applicator22 is positioned at the desired treatment site, the radio-frequency generator20 is activated to provide suitable energy, preferably at a selected frequency in the range of 10 megahertz to 1000 megahertz, to heat the scar tissue to a temperature sufficient to reduce the surface area of the scar without ablating the scar tissue or damaging the healthy tissue surrounding the infarctedarea12.
It should be understood that the devices taught in U.S. Pat. No. 6,071,303 are located external to the heart. However, I have found that in certain circumstances it can be preferable to apply heat in the internal surface of the heart. For example, in some cases the scar tissue is more severe or larger or both, within the heart than on the surface. Also, the use of the devices taught in U.S. Pat. No. 6,071,303 can require conventional open chest surgery. However, in some cases it is desirable for the surgeon to gain access to the patient's heart by catheterization.
OVERVIEWIt is an object of the present invention to provide a means to apply heat to a patient's infarct scar using a device deployed by a catheterization procedure so that the device is located inside the heart.
It is another object of the present invention to provide a means to apply heat to a patient's infarct scar using a device located inside the heart to raise the temperature of the scar in the desired treatment area to a controlled temperature sufficient to reduce the surface area of the scar without ablating the scar tissue or damaging the healthy tissue surrounding the infarcted portion.
It is another object of the invention to provide a means to locate a patient's infarct scar.
BRIEF DESCRIPTION OF THE DRAWINGSThe accompanying drawings, which are incorporated into and constitute a part of this specification, illustrate one or more embodiments of the present invention and, together with the detailed description, serve to explain the principles and implementations of the invention.
In the drawings:
FIG. 1 is a view of a conventional system for the treatment of infarcted heart tissue.
FIG. 2 is a view of another conventional system for the treatment of infarcted heart tissue.
FIG. 3 is a view of a system for the treatment of infarcted heart tissue according to a preferred embodiment of the present invention, with portions removed for clarity and to show internal components.
FIG. 4 is a view of the system shown inFIG. 3, taken along line4-4 ofFIG. 3
FIG. 5 is a view a portion of the system ofFIG. 3 illustrating its operation.
FIG. 6 is another view of the system ofFIG. 3 illustrating its operation as the heart contracts.
FIG. 7 is another view of the system ofFIG. 3 illustrating its operation as the heart relaxes.
FIG. 7ais view of an alternative embodiment.
FIG. 7bis another view of the alternative embodiment ofFIG. 7a.
FIG. 8 is an alternative embodiment of the present invention.
FIG. 9 is a view of the embodiment ofFIG. 8 with the mylar removed.
FIG. 10 is a view of another embodiment with part not shown to illustrate internal components.
FIG. 11 is a view of another embodiment.
FIG. 12 is a view of still another embodiment, shown with a portion of a patient to illustrate operation of the device.
FIG. 13 is a view of still another embodiment.
DETAILED DESCRIPTIONEmbodiments of the present invention are described herein in the context of a system and method for treatment of infarcted heart tissue. Those of ordinary skill in the art will realize that the following detailed description of the present invention is illustrative only and is not intended to be in any way limiting. Other embodiments of the present invention will readily suggest themselves to such skilled persons having the benefit of this disclosure. Reference will now be made in detail to implementations of the present invention as illustrated in the accompanying drawings. The same reference indicators will be used throughout the drawings and the following detailed description to refer to the same or like parts.
In the interest of clarity, not all of the routine features of the implementations described herein are shown and described. It will, of course, be appreciated that in the development of any such actual implementation, numerous implementation-specific decisions must be made in order to achieve the developer's specific goals, such as compliance with application- and business-related constraints, and that these specific goals will vary from one implementation to another and from one developer to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking of engineering for those of ordinary skill in the art having the benefit of this disclosure.
Turning toFIGS. 3-7, the first embodiment of the present invention includes acatheter31 and acollapsible heater30 attached to the distal end of the aflexible cable41. Thecable41 is located in the lumen of thecatheter31 so that thecable41 can slide therein.
Thecollapsible heater30 comprises aring40 mounted to the distal end of theflexible cable41, and a plurality ofstruts42 are mounted with their proximal ends affixed to thering40. Thestruts42 are flexible and spring-like so that they can flex toward and away from the center axis of thering40. At the distal ends of the struts42 aflexible wire44 is mounted in a circular configuration to limit the outward motion of the distal ends of thestruts42. Acenter electrode46 is located along the center axis of thering40, and a plurality ofoutside electrodes48 are mounted to thewire44. Thecenter electrode46 andoutside electrodes48 are electrically connected to a radio-frequency generator50 that is located outside the patient's body. Amylar sheet52 forms a bag-like structure which is located around the collapsible heater to completely enclose thestruts42,wire44 andelectrodes46 and48, and the proximal end of themylar sheet52 is connected to thering40. (Themylar sheet52 is shown inFIGS. 6 and 7 but omitted fromFIGS. 3 and 4 to permit the internal components to be seen.) Alternatively, the electrodes may be an integral part of themylar sheet52, with one configuration that the electrodes are printed in electrically-conductive ink on the mylar. Also, the mylar itself can act as a restraint on thestruts42, obviating the need forwire44.
Anattachment member70 extends through thecable41 and from the distal end of thecollapsible heater30. Theattachment member70 comprises a thin,flexible rod72 which extends through a lumen in thecable41 and through a lumen in thecenter electrode46. A corkscrew-shapedconnector74 is located at the distal end of therod72, and ahandle76 is located at the proximal end of therod72 so that a user can rotate thehandle76 to cause the corkscrew-shapedconnector74 to rotate.
To operate the device shown inFIGS. 3-7, first a physician introduces acatheter31 into a patient so that the distal end of thecatheter31 is located in the interior of the patient's heart according to conventional procedures. The physician then inserts thecollapsible heater30 into the proximal end of thecatheter31 so that thecollapsible heater30 is in the collapsed orientation in which thestruts42 are substantially parallel to each other. This can be accomplished with or without a conventional guidewire. In the case a guidewire is used, alumen56 is provided which extends through thecable41 and through thecenter electrode46 of the RF heater. The physician then pushes thecable41 to force thecollapsible heater30 through thecatheter31 until thecollapsible heater30 is near the distal end of the catheter, as shown inFIG. 5. As the physician continues to push thecable41, thecollapsible heater30 exits the distal end of thecatheter31 and expands to the deployed orientation as shown inFIG. 3.
When thecollapsible heater30 is positioned at the desired treatment site, the radio-frequency generator50 is activated to provide suitable energy, preferably at a selected frequency in the range of 10 megahertz to 1000 megahertz, to heat the scar tissue to a temperature sufficient to reduce the surface area of the scar without ablating the scar tissue or damaging the healthy tissue surrounding theinfarcted area12. Preferably, the emitted energy is converted within the scar tissue into heat in the range of about 40 degrees Celsius to about 75 degrees Celsius, more preferably in the range of about 60 degrees Celsius to about 65 degrees Celsius. The radio-frequency energy is preferably applied at low power levels (e.g., 1 to 20 watts). Suitable radio-frequency power sources are readily commercially available. Moreover, the radio-frequency energy can be multiplexed by applying the energy in different patterns over time as appropriate. In one embodiment, the radio-frequency generator20 has a single channel, delivering approximately 1 to 20 watts of energy and possessing continuous delivery capability. A feedback system can be connected to thecollapsible heater30 for detecting appropriate feedback variables for temperature control. For example, temperature sensing by way of athermocouple54 mounted on the distal end of thecenter electrode46 may be incorporated to provide feedback to modulate power from theRF generator50 or other energy source through afeedback loop56 and/or software within thegenerator50 or connector/cable. Alternatively, other feedback systems could be employed, e.g. a thermistor could be mounted to themylar sheet52 in a location to contact the infarct scar.
Turning now toFIGS. 6 and 7 other aspects of the present invention are shown. It should be understood that it is important to locate thecollapsible heater30 in close proximity to or touching theinfarcted portion12. It should also be understood that in some cases theinfarcted portion12 is somewhat thinner and weaker than the adjacent, healthy portion of the heart, and consequently when the heart muscles contract the infarcted portion bulges outward from its normal configuration, as indicated inFIG. 6. When this occurs there tends to be blood flow toward the bulge as suggested byarrows60. Accordingly, thecollapsible heater30 acts like a sail and is carried toward the bulge by the blood flow. Thus thecollapsible heater30 can be said to be self-positioning. It should be understood that to facilitate this self-positioning feature at least theflexible cable41 and in some cases, both theflexible cable41 and thecatheter31, must be considerably different from a conventional catheter. Specifically, a conventional catheter is relatively rigid and can include structures to permit a physician to manipulate the distal end of the catheter from a location external to the patient. Such a catheter can be called a “steerable” catheter. In contrast, in the present invention, at least theflexible cable41 and in some cases, both theflexible cable41 and thecatheter31 must be quite flexible to allow the blood flow to move the collapsible heater. For this reason, the flexible cable is shown inFIGS. 6 and 7 as somewhat limp, and thecatheter31 can be understood to be a flexible tube, without the components often found in a conventional steerable catheter which to permit a physician to manipulate the distal end of the catheter from a location external to the patient. Similarly, the flexible tube does not include components which permit a physician to manipulate the distal end of the flexible tube from a location external to the patient.
As the heart continues to pump, the collapsible heater is carried toward theinfarcted portion12 until the distal end of the corkscrew-shapedconnector74 contacts the infarct. Then the physician can rotate thehandle76 to rotate the connector so that the connector engages the infarct and pulls the collapsible heater into contact with the infarct, shown inFIG. 7. Then when the physician applies RF energy to theheater30 the energy is applied directly to the infarct and is not dissipated into blood between theheater30 and theinfarct12 as would be the case if theheater30 were spaced apart from theinfarct12. When the procedure is complete, the physician rotates thehandle76 to release theconnector74 from theinfarct12.
Turning now toFIGS. 7aand7banother embodiment is shown. The embodiment ofFIGS. 7aand7bcomprises aheater locating system110 which comprises aheater112 which is similar to thecollapsible heater30, except that theheater112 includes anultrasonic crystal114 mounted at the distal end of thecenter electrode46. Theheater locating system110 further comprises alocating device116 including an ultrasonic crystal array which is located outside thepatient106 and which allows a physician to determine the location of theultrasonic crystal114. The system ofFIGS. 7a-7bfurther includes asteerable catheter120, and theheater112 is mounted to the distal end of thesteerable catheter120. In operation, theheater112 is introduced into the patient's heart in the same way as is thecollapsible heater30 as discussed above. The physician uses thelocating device116 to monitor the location of the ultrasonic crystal and theheater112, and the physician uses thesteerable catheter120 to locate the heater adjacent theinfarct12. Then the physician uses theheater112 to heat the infarct scar in the same way as thecollapsible heater30 as discussed above and illustrated inFIGS. 6 and 7.
It should be understood that other types of monitoring and locating systems could be used by a physician to monitor the location of a heater and locate the heater adjacent an infarct scar.
FIGS. 8-10 show another embodiment which includes an alternative means to connect aheater78 to theinfarct12. In this embodiment, theheater78 is similar toheater30 in most respects, except that inheater78 theattachment member70 is absent, instead a plurality ofhooks80 are disposed around the periphery of thewire44. Thehooks80 are concave with their middle portions being closer to central axis of theheater30 than their top and bottom portions. In operation, thecollapsible heater78 withhooks80 is pushed through thecatheter31 until it nears the distal end of the catheter. At this point the distal end of thecatheter31 is positioned adjacent the infarct. Then as the collapsible heater exits the distal end of thecatheter31, as shown inFIG. 9 thestruts31 begin to move away from their collapsed orientation and thehooks80 engage the infarct as shown inFIG. 10. The physician then heats the infarct as explained above. Thereafter, when heating has been completed, thehooks80 are released from theinfarct12 by sliding the distal end of the catheter over thestruts42, which causes thehooks80 to disengage from theinfarct12 to allow removal of the collapsible heater from the heart.
Optionally, as shown inFIG. 10, inheater78strain gauges82 are connected to thestruts42 and thering40 to measure flexion of the struts relative to thering40, and signals from the strain gauges are carried by wires, not shown, to a meter84 located outside the patient. (InFIG. 10 themylar sheet52 is not shown, in order to illustrate internal components.) This permits measurement of the extent to which the infarcted portion has been treated. Specifically, when thehooks80 are affixed to infarcted portion the strain measured by thestrain gauge82 is recorded. Then when heat is applied to theinfarcted portion12 the infarcted portion shrinks which causes the distal ends ofstruts42 to be drawn toward each other, which in turn causes a change in the strain measured by the strain gauges82. When the measured strain stops changing it is known that the infarcted portion is completely treated and will not shrink further. At this time heating is discontinued and theheater78 is removed.
Turning now toFIG. 11 one example of an alternative heater is shown. According to the embodiment shown inFIG. 11 acollapsible heater90 is similar toheater78 in most respects, except that inheater90 there are nocenter electrode46 oroutside electrodes48. Rather, there is an infraredlight source92 which is connected to a controllable power supply, not shown, to heat the infarct region.
Turning now toFIG. 12 another embodiment is shown. It should be understood that in the embodiments discussed above, the self-locating aspect of the invention is applied to locating a heater. On the other hand, in the embodiment ofFIG. 12 the self-locating feature is not employed to locate a heater but is employed to locate theinfarct12 for other purposes. In certain medical procedures it is important for a physician to be able to accurately locate an infracted region of the heart. One example is to perform electro physiologic ablation using a conventional device. Accordingly, the embodiment ofFIG. 12 comprises aninfarct locator100 which is similar to thecollapsible heater30, except that theinfarct locator100 does not include heating elements, and theinfarct locating system102 comprises anacoustic imaging device104 which is located outside thepatient106 and which allows a physician to determine the location of theinfarct locator100. In operation, theinfarct locator100 is introduced into the patient's heart in the same way as is thecollapsible heater30 as discussed above. Then the infarct locator is located adjacent theinfarct12 by its self-positioning features in the same way as is thecollapsible heater30 as discussed above and illustrated inFIGS. 6 and 7. The physician can use theacoustic imaging device104 to monitor the location of theinfarct locator100, or other means such as X-ray imaging can be used.
Turning now toFIG. 13 another embodiment is shown. This embodiment is similar to the embodiment shown inFIGS. 3-7. However, theFIG. 13 embodiment includes a system to assist in locating the infarct scar by measuring certain electrical properties of the heart tissue. It should be understood that an infarct scar has resistivity which is greater than that of normal heart muscle and conversely the conductivity of the infarct scar is less than that of normal heart muscle. Moreover, whereas normal heart muscle generates electrical signals, an infarct scar generates no electrical signals. Accordingly, the device ofFIG. 13 measures electrical properties of the heart tissue to determine the conductivity, the resistivity or the electrical signals generated by the tissue to thereby ascertain whether the tissue is normal or an infarct scar. To accomplish this a conventionalelectrical monitoring system130 is connected to thecenter electrode46 and to theoutside electrodes48, and theelectrodes46 and48 are used are used to transduce electrical signals as necessary.
While embodiments and applications of this invention have been shown and described, it would be apparent to those skilled in the art having the benefit of this disclosure that many more modifications than mentioned above are possible without departing from the inventive concepts herein. The invention, therefore, is not to be restricted except in the spirit of the appended claims.